Between June and September 2013, sera from 11 dromedary camels, 150 goats, 126 sheep and 91 cows were collected in Jordan, where the first human Middle-East respiratory syndrome (MERS) cluster appeared in 2012. All sera were tested for MERS-coronavirus (MERS-CoV) specific antibodies by protein microarray with confirmation by virus neutralisation. Neutralising antibodies were found in all camel sera while sera from goats and cattle tested negative. Although six sheep sera reacted with MERS-CoV antigen, neutralising antibodies were not detected.
In the period between June and September 2013, sera from 11 dromedary camels, 150 goats, 126 sheep and 91 cows were collected predominantly in the al Zarqa governorate, Jordan, where the first human Middle-East respiratory syndrome (MERS) cluster appeared in April 2012 [1] . All sera were tested for the presence of MERScoronavirus (MERS-CoV) specific antibodies by protein microarray with confirmation by virus neutralisation. Neutralising antibodies to MERS-CoV were found in all sera from dromedary camels while the sera from goats and cattle tested negative. Although six of 126 sheep sera reacted with the MERS-CoV antigen, neutralising antibodies were not detected. The reactivity of sheep sera from this region observed in the microarray warrants further study.
Background
In 2012 MERS-CoV was identified in patients with severe respiratory disease in the Middle East. As of 2 December 2013, a total of 163 laboratory-confirmed cases including 70 deaths have been reported to the World Health Organization (WHO) [2] . All cases reported to date were linked to Jordan, Kuwait, Oman, Qatar, Saudi Arabia (SA) or the United Arab Emirates (UAE). Human to human transmission has been observed in healthcare and family settings [3] . Various studies indicate that the observed MERS-CoV diversity in humans results from multiple independent introductions in the human population in the Middle East [5] [6] [7] and the number of these sporadic, primary infections is still increasing [2] . The animal reservoir(s) for MERS-CoV are still unknown but serological studies demonstrated that dromedary camels in the Canary Islands, Egypt and Oman have been infected with MERS-CoV or MERS-related-CoV [8, 9] . Of these countries, human cases have only been detected in Oman [2] .
Data provided by the Food and Agriculture Organization of the United Nations (FAO) from 2012 show that cows, dromedary camels, goats and sheep are the main sources of meat and milk in the affected countries [4] . In addition, in Saudi Arabia, where the majority of MERS cases have been reported, roughly one sheep is sacrificed for each pilgrim or one camel for seven pilgrims in the Hajj (yearly Muslim pilgrimage to Mecca), which can amount up to the slaughter and worldwide distribution of meat of around three million Middle-Eastern sheep and camels, based on the pilgrim numbers reported for 2011 and 2012 [10] . The continued occurrence of human MERS cases, the presence of neutralising antibodies in camels and the extensive animal exposure (including animal products) of humans warrant extensive studies in livestock aimed at identifying the possible reservoir of MERS-CoV. In April 2012, an outbreak of acute respiratory illness occurred in an intensive care unit in a public hospital in Zarqa city, Zarqa governorate, Jordan. Retrospective testing identified MERS-CoV as the confirmed and probable causative agent of two and 11 patients respectively. Ten people in the outbreak were healthcare workers (HCW). The two confirmed cases, a HCW and an admitted patient, died [1] . Although epidemiological investigations identified limited nosocomial transmission, the primary source for MERS-CoV transmission to humans was not identified.
Middle East Respiratory Syndrome coronavirus serological study in livestock
Between June and September 2013, sera as well as faecal swabs from 11 dromedary camels, 150 goats, 126 sheep and 91 cows were collected predominantly in the al Zarqa governorate, Jordan (Table 1, Figure 1 ). All sera were tested for the presence of IgG antibodies reactive with MERS-CoV, Severe Acute Respiratory Syndrome coronavirus (SARS-CoV), and human coronavirus OC43 (HCoV-OC43) S1 antigens exactly as described before [9, 11] . HCoV-OC43 is serologically closely related to bovine coronavirus (BCoV) and used as a proxy to detect antibodies against BCoVs that are commonly circulating in ungulates [9] .
All 11 dromedary camel sera and six of 126 sheep sera had antibodies against the MERS-CoV S1 antigen while there was no reactivity in goat and cow sera. Four of 11 dromedary camels, 23/91 cows, 128/150 goats and all sheep reacted with HCoV-OC43 antigen. None of the sera bound to SARS-CoV antigen ( Figure 2 ).
For confirmation, all camel and sheep sera (n= 137) were tested in a MERS-CoV neutralisation assay, exactly as described before [9] . All camel sera had MERS-CoV neutralising antibodies with titres varying between 1:20 and 1:80, while no neutralising antibodies were detected in the sheep sera ( Table 2 and data not shown). As coronavirus serology is potentially complicated due to the general circulation of BCoVs in these four livestock species (cross-reactivity needs to be excluded), a comparative plaque reduction neutralisation test (PRNT) for MERS-CoV and BCoV was performed on all camels sera and a subset of goat, sheep and cow sera, exactly as described before [9] ( Table  2 ). All camel sera inhibited MERS-CoV plaque formation with titres varying between 1:40 and 1:80, while again no inhibition was observed with the selection of sheep sera. Four of the 11 camel sera also inhibited BCoV plaque formation with titres between 1:160 and 1:320, confirming the microarray results for these samples. BCoV neutralising titres varied between 1:40 and 1:160 for the selection of sheep sera, between 1:40 and 1:320 for the subset of goat sera and between 1:40 and 1:>1,280 for the subset of bovine sera.
Faecal samples of camels and sheep were analysed for identification of viral sequences using pancoronavirus and specific polymerase chain reaction (PCR) methods [9] . Three BCoV sequences but no MERS-CoV or MERSrelated CoV sequences were obtained from sheep rectal swabs.
Discussion
Here, we describe a serological study in various livestock species (n= 378) of economic importance in a a The letters B, C, D, E, and F refer to locations indicated in Figure 1 . b If known, it is indicated whether the animals were kept indoors or outdoors. c The respective locations of the sheep and camels were 5 km apart and there was no contact between the sheep and camels. d Females were older than 2 years and males were younger than 6 months.
Figure 2
Reactivity of livestock sera (n= 378) from Jordan with three coronavirus S1 antigens Positive BCoV neutralisation titre b n (titres) Dromedary camels n= 11 MERS-CoV antigen array signal (RFU) <10,000 0 0 (NS) 0 (NS) 10,000-20,000 0 0 (NS) 0 (NS) 20,000-30,000 0 0 (NS) 0 (NS) 30,000-40,000 2 2 (1:20 to 1:40) 0 (NS) >40,000 9 9 (1:20 to 1:80) 4 (1:160 to 1:320) hCoV-OC43 antigen array signal (RFU) <10,000 9 9 (1:20 to 1:80) 2 (1:320) 10,000-20,000 2 2 (1:80) 2 (1:160) 20,000-30,000 0 0 (NS) 0 (NS) 30,000-40,000 0 0 (NS) 0 (NS) >40,000 0 0 (NS) 0 (NS) Sheep n= 10 MERS-CoV antigen array signal (RFU) <10,000 4 0 (NS) 3 (1:80 to 1:160) 10,000-20,000 0 0 (NS) 0 (NS) 20,000-30,000 1 0 (NS) 1 (1:40) 30,000-40,000 2 0 (NS) 2 (1:40 to 1:160) >40,000 3 0 (NS) 2 (1:40 to 1:80) hCoV-OC43 antigen array signal (RFU) <10,000 1 0 (NS) 0 (NS) 10,000-20,000 0 0 (NS) 0 (NS) 20,000-30,000 1 0 (NS) 0 (NS) 30,000-40,000 2 0 (NS) 2 (1:40) >40,000 6 0 (NS) 6 (1:40 to 1:160) Goat n= 8 MERS-CoV antigen array signal (RFU) < 10,000 7 0 (NS) 3 (1:40 to 1:320) 10,000-20,000 1 0 (NS) 1 (1:160) 20,000-30,000 0 0 (NS) 0 (NS) 30,000-40,000 0 0 (NS) 0 (NS) >40,000 0 0 (NS) 0 (NS) hCoV-OC43 antigen array signal (RFU) <10,000 3 0 (NS) 0 (NS) 10,000-20,000 0 0 (NS) 0 (NS) 20,000-30,000 0 0 (NS) 0 (NS) 30,000-40,000 1 0 (NS) 0 (NS) >40,000 4 0 (NS) 4 (1:40 to 1:320) Bovine n= 7 MERS-CoV antigen array signal (RFU) <10,000 7 0 (NS) 7 (1:80 to 1: >1,280) 10,000-20,000 0 0 (NS) 0 (NS) 20,000-30,000 0 0 (NS) 0 (NS) 30,000-40,000 0 0 (NS) 0 (NS) >40,000 0 0 (NS) 0 (NS) hCoV-OC43 antigen array signal (RFU) <10,000 4 0 (NS) 4 (1:80 to 1:160) 10,000-20,000 3 0 (NS) 3 (1:160 tp 1: >1,280) 20,000-30,000 0 0 (NS) 0 (NS) 30,000-40,000 0 0 (NS) 0 (NS) >40,000 0 0 (NS) 0 (NS) region in Jordan where a cluster of human MERS cases occurred.
No evidence for the presence of antibodies directed against MERS-CoV was found in 91 cattle and 150 goat sera. MERS-CoV neutralising antibodies were found in all 11 dromedary camel sera. Circulation of BCoV in dromedary camels is known but cross-neutralisation between MERS-CoV (a lineage C beta-coronavirus) and BCoV (a lineage A beta-coronavirus) or other CoVs, including SARS-CoV (a lineage B betacoronavirus), has been conclusively excluded in previous studies and was illustrated again in this study in the comparative PRNTs [8, 9] . These observations indicate that MERS-CoV or a highly related virus circulated in dromedary camels in a region where transmission to humans occurs.
The neutralisation titres observed in the Jordan camel sera were lower than observed with sera from Oman but in the same range as those observed on the Canary Islands [9] . The dromedary camels in this study were calves, only three to 14 months of age, and these low titres might reflect the presence of waning maternal antibodies. However, maternal antibodies in dromedary camels reportedly decline rapidly two to five weeks after birth [12] and much higher antibody titres against MERS-CoV were observed in adult dromedary camels (older than four years of age) in the Middle-East region and the Horn of Africa [8, 9] (and data not shown). Therefore an alternative explanation could be that the camels had just been infected and antibody titres were still rising.
Interestingly, six sheep sera reacted with MERS-CoV S1 antigen on the array while previous validation experiments using sheep sera from the Netherlands showed no reactivity [9] . This previous study included HCoV-OC43 S1-reactive and non-reactive sheep sera emphasising that there should not be any cross-reactivity between the MERS-CoV antigen and BCoV-specific antibodies due to BCoV circulation. However, none of the 126 sheep sera showed MERS-CoV neutralising activity. The applied sheep sera were highly haemolytic which may have caused some assay interferences.
Our observation strengthens our earlier study in which MERS-CoV neutralising antibodies were found in dromedary camels in Oman where human cases have been reported as well [2] . Until the virus that elicits these antibodies in camels is detected, sequenced and compared to the viruses sequenced from human patients, it remains unclear whether this livestock species is indeed infected with MERS-CoV and thus represents an immediate source for human infection. However, our observations should be used to focus virological and serological studies in livestock, especially dromedary camels and sheep, and including humans handling these animals and their products.
